Wolverine Asset Management’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-206,000
| Closed | -$2.94M | – | 1823 |
|
|
2018
Q4 | $2.94M | Sell |
206,000
-10,000
| -5% | -$199K | 0.04% | 422 |
|
|
2018
Q3 | $4.5M | Sell |
216,000
-5,000
| -2% | -$118K | 0.05% | 342 |
|
|
2018
Q2 | $5.23M | Buy |
221,000
+100,400
| +83% | +$2.02M | 0.07% | 269 |
|
|
2018
Q1 | $1.76M | Sell |
120,600
-225,200
| -65% | -$3.68M | 0.02% | 581 |
|
|
2017
Q4 | $5.59M | Buy |
345,800
+114,500
| +50% | +$1.35M | 0.06% | 267 |
|
|
2017
Q3 | $3.23M | Sell |
231,300
-7,900
| -3% | -$78.7K | 0.04% | 353 |
|
|
2017
Q2 | $2.11M | Sell |
239,200
-33,100
| -12% | -$232K | 0.03% | 428 |
|
|
2017
Q1 | $1.76M | Buy |
272,300
+56,800
| +26% | +$288K | 0.03% | 419 |
|
|
2016
Q4 | $790K | Sell |
215,500
-1,700
| -0.8% | -$5.03K | 0.01% | 585 |
|
|
2016
Q3 | $705K | Buy |
217,200
+45,400
| +26% | +$127K | 0.01% | 629 |
|
|
2016
Q2 | $398K | Buy |
171,800
+171,220
| +29,521% | +$572K | 0.01% | 753 |
|
|
2016
Q1 | $23K | Sell |
580
-4,541
| -89% | -$10.2K | ﹤0.01% | 970 |
|
|
2015
Q4 | $314K | Sell |
5,121
-749
| -13% | -$2.09K | 0.01% | 759 |
|
|
2015
Q3 | $1.02M | Sell |
5,870
-44
| -0.7% | -$112 | 0.02% | 503 |
|
|
2015
Q2 | $598K | Sell |
5,914
-1,408
| -19% | -$5.76K | 0.01% | 590 |
|
|
2015
Q1 | $701K | Buy |
7,322
+6,766
| +1,217% | +$29.4K | 0.01% | 531 |
|
|
2014
Q4 | $16K | Buy |
556
+114
| +26% | +$451 | ﹤0.01% | 1673 |
|
|
2014
Q3 | $9K | Buy |
442
+2
| +0.5% | +$7 | ﹤0.01% | 2020 |
|
|
2014
Q2 | $15K | Hold |
440
| – | – | ﹤0.01% | 1772 |
|
|
2014
Q1 | $25K | Sell |
440
-10
| -2% | -$50 | ﹤0.01% | 1572 |
|
|
2013
Q4 | $29K | Buy |
+450
| New | +$2K | ﹤0.01% | 1956 |
|
Wolverine Asset Management's IMMU Position: Q4 2020 in Review
Wolverine Asset Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 59,991 shares — an estimated $5.1M sold.
Wolverine Asset Management first reported a position in IMMU in Q2 2013 and held it in 10 quarters. The position peaked at $5.74M in Q3 2017. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Wolverine Asset Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Wolverine Asset Management sold 59,991 Immunomedics Inc shares in Q4 2020, an estimated $5.1M.
- Wolverine Asset Management first reported a position in Immunomedics Inc in Q2 2013 and held it in 10 quarters.
- Wolverine Asset Management's Immunomedics Inc position peaked at $5.74M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Wolverine Asset Management's 13F filing for Q4 2020, filed 12 Feb 2021.